25
March
2024


Share on networks

The manager Stoneshield Capital, through its Life Science and innovation platform, Deeplabs, has completed the acquisition of five assets located in the towns of Sant Joan Despí and Esplugues de Llobregat, with the ambition of establishing the first nerve center for science and innovation in Catalonia.

This project, called Barcelona Science Innovation District (BaSID), represents a significant investment of more than 200 million euros and will cover a total area of approximately 75,000 square meters.

The main objective of Stoneshield Capital is to promote Barcelona as a benchmark in infrastructure for science and innovation. As explained by Javier de Pablo, co-CEO of Deeplabs, «BaSID will become the first private Life Science hub in Catalonia», offering cutting-edge facilities for companies, entities and research centers that demand this type of space, which are currently scarce in Spain.

BaSID has as its model the successful MaSID, the first Life Science innovation hub in Spain, located in Tres Cantos (Madrid), where numerous companies in the sector operate. This scientific and technological district approach, led by Deeplabs, has precedents in other countries but represents a novelty in Spain. According to Pilar Gil, co-CEO and CSO of Deeplabs, this initiative introduces a new standard of advanced scientific hub, crucial to improving the competitiveness of the sector in the country.

Share on networks

Related news

El districte tecnològic 22@ duplica la contractació d’oficines i assoleix els 93.000 m2 gràcies a les telecomunicacions i la IA

News

Office space leased in Barcelona’s 22@ technology district doubles, hitting 93,000 m2, thanks to telecoms and AI

Penguin Random House inverteix 36 milions al seu centre de distribució de llibres de Barcelona, el més avançat d’Europa

News

Penguin Random House invests €36 million in Barcelona book distribution centre, most advanced in Europe

Sanofi ubicarà a Barcelona el seu hub d’excel·lència global especialitzat en intel·ligència artificial (IA) i R+D

News

Sanofi to establish global centre of excellence in AI and R&D in Barcelona

Barcelona Catalonia
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.